Dr Leearne Hinch Chief Executive Officer Biotechnology CEO with a successful track record in corporate development, capital raising, product development, commercialisation and licensing.

2002年5月22日 · Leearne Maree Hinch is currently the Chief Executive Officer at INOVIQ Ltd. and a Director at BARD1AG SA. Previously, she held positions as the Chief Executive Officer at Chemeq Ltd., Immuron Ltd., Holista CollTech Ltd., Virbac (Australia) Pty Ltd., Eustralis Pharmaceuticals Ltd., and Wellfully Ltd.

Dr Leearne Hinch is a biotechnology executive and consultant with extensive experience in the life science industry in general management, strategy, fundraising, business development and commercialisation.

Dr. Leearne Hinch serves as Chief Executive Officer at INOVIQ.She is a biotechnology executive and consultant with extensive experience in the life science industry in general management, strategy, fundraising, business development and commercialization.

2023年7月10日 · Dr Leearne Hinch: Last week, we reported excellent clinical results from our SubB2M/CA15-3 test for breast cancer. Essentially, we showed that our test performed with 81 per cent sensitivity ...

2015年4月2日 · Dr Leearne Hinch is a biotechnology executive and consultant with over 20 years’ experience in the lifescience industry, with particular strengths in general management, strategy, fundraising, technology commercialisation, business development and …

Leearne Hinch is an accomplished executive in the biotechnology and life sciences sectors, currently serving as CEO of INOVIQ Ltd since November 2016, where innovative diagnostic technologies for cancer are developed.

Currently serving as the CEO of BARD1 Life Sciences Ltd, Dr. Hinch is in charge of providing strategic leadership, advancing the company's diagnostics pipeline, and expanding its technologies. She has a proven track record in guiding and overseeing the development and commercialization of diagnostic, device, therapeutic, and animal health products.

Leearne Hinch is the current CEO of BARD1 Life Sciences. Leearne has also served as the CEO of Immuron Limited and the COO of OBJ Limited. In addition to their work in the corporate world, they have also served as a consultant and interim CEO for Eustralis Pharmaceuticals Ltd and as the managing director for Ingeneus Solutions Pty Ltd.